1. Bladder Cancer: Management and Future Directions
Christopher P. Evans, Frans M.J. Debruyne, Heather Payne, Eduardo Solsona, Pierre Teillac, Andrea Tubaro 
European Urology Supplements 
Volume 6, Issue 3, Pages (March 2007)
DOI: /j.eursup
Copyright © 2006 European Association of Urology Terms and Conditions

2. Fig. 1 Management of a patient with a noninvasive papillary lesion.
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2006 European Association of Urology Terms and Conditions

3. Fig. 2 Management of a patient with invasive bladder carcinoma.
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2006 European Association of Urology Terms and Conditions

4. Fig. 3
Chemotherapy prior to local therapy versus local therapy alone [38]. Reprinted from Winquist E, et al. J Urol 2004;171:561–9. Copyright 2004, with permission from the American Urological Association.
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2006 European Association of Urology Terms and Conditions

5. Fig. 4
Time to progression in T1 G3 patients by carcinoma in situ. O=observed number of progressions, N=number of patients [43]. Reprinted from Sylvester RJ, et al. Eur Urol 2006;49:466–75. Copyright 2006, with permission from Elsevier Inc.
European Urology Supplements 2007 6, DOI: ( /j.eursup )
Copyright © 2006 European Association of Urology Terms and Conditions